The hydrolysis of adenosine 3-monophosphate by serum acid phosphatase has been coupled to the liberation of ammonia from the adenosine generated through the action of exogenous adenosine deaminase. The ammonia is measured at the end of the incubation by a modification of the phenol-hypochlorite reaction of Berthelot. Optimum conditions for the enzyme reaction have been defined. Inhibition of the Berthelot reaction by the serum used in the assay is small, and may be compensated by a correction factor. Although the value for the control is high in relation to Ehe test over the normal range, this is largely outweighed by the good sensitivity and precision of the method.
3'AMP can be coupled through adenosine deaminase (ADase, EC 3.5.4.4, adenosine aminohydrolase) to produce inosine and ammonia under conditions optimal for AcPase The decrease in extinction at 265 nm consequent upon conversion of adenosine to inosine may be measured spectrophotometrically and provides a method that is rapid and sensitive employing tissue preparations with moderate AcPase activity, but cannot cope with the high absorbance of serum at the wavelength used. An alternative possibility lay in determining ammonia production utilizing the phenol-hypochlorite reaction of Berthelot as modified by Chaney and Marbach (1962) . This procedure is described in the present paper, which also presents some preliminary clinical data comparing the proposed method with The derivation of the factor 104 which corrects for depression of the Berthelot reaction by serum is described later.
Results

DEVELOPMENT OF THE METHOD
Choice of buffer A pH activity curve was constructed over the range 4-5-6-5 using 01 M acetate and 0.1 M citrate buffers.
The pH was measured at 37°C before and after incubation, using the Micro-Astrup apparatus (Radiometer Corporation, Copenhagen, Denmark). Optimal activity was obtained at pH 5-6 with both buffers (Fig. 1) 
Choice of substrate
The criteria governing this choice were that the substrate should have a high affinity towards prostatic AcPase aaid low affinity towards erythrocyte AcPase. Of the monophosphates of adenosine tested, 3'AMP best fulfilled these criteria (Table II) . This enabled the use of a correction factor to allow for this inhibition. Using 50 ,ul serum and the conditions of the enzyme assay, the percentage recovery of ammonia obtained with 24 sera gave a mean ± SD of 95 9 ± 3 1, hence the factor of 1 04 used in calculation of enzyme activity. This may be employed only for determinations at pH 5-6 with 50 ,ul serum.
When the colour was developed at 56°C, not only was the yield reduced, but the colour became progressively unstable as the amount of serum was increased. Other studies to overcome this inhibition were unsuccessful. They were similar to experiments described in an earlier report (Belfield, Ellis, and Goldberg, 1970) .
Characteristics of enizyme reaction
The definitive procedure yielded activity proportional to the amount of enzyme up to LE630 of 1-10, corresponding to approximately 58 IU/litre. The reaction, even with sera of very high activity, was linear with time up to at least one hour. It is recommended that assays should be repeated using a shorter incubation time where LE630 after one hour exceeds 1-10; this maintains the validity of the correction factor used in calculating activity.
The within-batch precision of the method gauged by 13 replicate assays of a serum gave a mean of 501 IU/l with the coefficient of variation = 2-4%.
The SD of pooled duplicates was derived according to Pearson (1942) from analyses on the 137 patients in group C. The range and median value of this case material is given in Table IV This was tested by drawing a large sample of venous blood from a patient with high activity due to advanced prostatic cancer. The serum was separated without delay and split into three major aliquots, one being untreated, a second being adjusted to a final concentration of 0-1 00 with respect to Triton X-100, and a third adjusted to a pH of approximately 6 0 by adding 10 ,ul of 20 % (v/v) acetic acid per millilitre serum. All three lost approximately 100/ activity due to the initial freezing, but thereafter no significant change took place at -20°C over a period of six months when fractions stored individually to avoid the need for repeated freezing and thawing were assayed. Neither was there any significant change in the three preparations when stored at 4°C for up to eight days; but at room temperature the activity of the untreated and detergent-treated preparations declined steadily, whereas the activity of the acid-treated preparation was unchanged (Fig. 2) .
OBSERVATIONS ON HUMAN SUBJECTS
The activities observed in the three groups of subjects studied are summarized in Table IV . Because the distribution was skewed in all groups, the data were plotted on probability paper to give the 95-percentile range. Where, as occasionally happened, the value for the control exceeded that of y = 1-00 + 031x, where y and x are AcPase activities in Gutman units and IU/l respectively. The standard errors of the slopes and intercept were 0 11 and 0-14 respectively. Clearly, the two methods are not reflecting an identical enzyme activity, values for the Gutman procedure being relatively greater at low AcPase levels, presumably because that method includes a contribution from erythrocyte AcPase. An analysis of those cases in group C where a value of 3-1 IU/I was exceeded appears in Table V the test, a negative activity was assigned to the sample so that the ranges take full account of the experimental error. The upper limit for the laboratory staff (group A) was lower than that of the elderly population (group B) which in turn was lower than the hospital population (group C), but the median values for all three were similar. The total AcPase activity of all patients in group C was also determined by the method of Gutman and Gutman (1940) . The upper normal limit for this laboratory is 3 units per 100 ml. Where this value was exceeded, the assay was repeated at the earliest opportunity in the presence of a final concentration of 05 % formaldehyde, a value in excess of 2 units per 100 ml being regarded as abnormal. A statistical analysis of the AcPase activities, as measured by the two methods in the same patients, yielded a correlation coefficient of 0-248 (p < 0-01) and the regression equation, Current experience thus suggests that serum AcPase activity < 3-1 IU/I by the present technique is normal, between 3-2 and 3-7 IU/I possibly abnormal, and > 3-7 IU/l definitely abnormal. These criteria should permit detection of a high proportion of cases of prostatic cancer, although the falsepositive rate is also likely to be high unless precautions are taken to avoid trauma to the prostate at the time of sampling. This problem may be accentuated by the higher specificity of 3'AMP for prostatic AcPase.
Discussion
CRITIQUE OF METHOD
The method presented is convenient and simple to perform. Although the colour given by the control is high in relation to that of the test in the normal range, the precision with which ammonia in both test and control can be measured is high and the sensitivity of the Berthelot reaction very great, so Graham Ellis, Alan Belfield, and David M. Goldberg that the measured extinction difference covers an adequate span in the normal range. The inclusion of a correction factor for inhibition of the Berthelot reaction by serum is designed to permit strict comparison on a molar basis between 3'AMP hydrolysis and that of other substrates. For purely clinical use it can probably be ignored, as it is small and consistent. The colour is read at 30 minutes, by which time it has declined 0 5 % from its peak value. This happens to be a matter of convenience in our laboratory, but the error in selecting any time between 15 and 40 minutes would be negligible.
SUBSTRATE SPECIFICITY
Since the work of Abul-Fadl and King (1949) , which described the differential effects of various inhibitors, including formaldehyde and L-tartrate, upon AcPase activity of several organs and cells, it has been common to describe tartrate-labile AcPase as 'prostatic'. This identity was never claimed by the original authors, and much subsequent work has shown the occurrence of tartrate-labile AcPase in other tissues, notably the liver (Nelson, 1966; Brightwell and Tappel, 1968) . A similar misconception has arisen regarding the use of a-naphthyl phosphate as substrate. Although claimed to be virtually specific for prostatic AcPase (Babson and Read, 1959; Babson and Phillips, 1966) , it has now been shown not to be so (Amador, Price, and Marshall, 1969) , and indeed many years earlier it was reported to be hydrolysed by an enzyme in female urine (Altschule, Parkhurst, and Zager, 1951) . Erythrocyte AcPase has a very low affinity for ,-glycerophosphate (Tsuboi and Hudson, 1953) , but the virtual identity of the range of values using this substrate found for serum AcPase activity of normal men and women (Woodard, 1959) precludes its specificity for prostatic AcPase. The unequivocal demonstration of prostatic AcPase in human serum would seem at present to rest with polyacrylamide gel electrophoresis (Rozenszajn, Epstein, Shoham, and Arber, 1968 (Belfield, Ellis, and Goldberg, 1970) ; the methods, when used in a routine laboratory, give unsatisfactory precision (Belfield and Goldberg, 1969) ; and contamination is a continual problem (Tsuboi and Hudson, 1953; Belfield and Goldberg, 1971) . Apart from its technical difficulties, determination of tartrate-labile AcPase appears to offer no advantage over total AcPase in the diagnosis of prostatic cancer (Murphy, Reynoso, Kenny, and Gaeta, 1969) and the case for continuing its use is difficult to sustain.
STABILITY OF SERUM ACPASE
This study was undertaken in view of the reported instability of prostatic AcPase (Tsuboi and Hudson, 1955; Kilsheimer and Axelrod, 1957) and serum AcPase (Jacobson, 1960) ; the first two sets of authors used Triton X-100 to stabilize the enzyme against surface inactivation while the latter author acidified the serum to prevent pH-dependent inactivation. It was thought that this instability might be the cause of frequent failure to confirm high values by the techniques of Gutman and Gutman (1940) when they were repeated the following day, although subsequently this was shown to be due to the poor precision of the method and its susceptibility to contamination by trace materials adsorbed on glassware. The present work shows (Fig. 2) that, provided the serum is promptly refrigerated, no other treatment is necessary; failing this, quite rapid inactivation occurs which is prevented by acidification but not by detergent. Once acidified, the serum may be kept several days at room temperature-certainly long enough to permit mailing of the sample to a central laboratory. Our findings regarding the stability of untreated serum are in good agreement with those of an earlier study (King and Jegatheesan, 1959) .
CLINICAL VALUE OF THE ASSAY
The significance of raised serum AcPase activity has been discussed by many authors. It has become established as a fact of laboratory medicine that when carcinoma of the prostate metastasizes to bone raised and indeed sometimes very high levels of AcPase are found in the serum of most but not by any means all patients (Gutman and Gutman, 1938; Woodard, 1959) . These earlier workers on the whole agree that raised levels occur in about half the cases where the metastases are to soft tissues only, and they are uncommon when the tumour remains within the confines of the prostatic capsule. Most of the recent reports based on fairly large surveys support this consensus (Veterans Administration, Cooperative Urological Research Group, 1968; Murphy et al, 1969; Prout, 1969; Amador et al, 1969; Marshall and Amador, 1969) . Indeed the point has been made by Marshall and Amador (1969) that no single case in their series was diagnosed on the basis of AcPase activity; in all their cases with raised values the diagnosis had already been reached by the clinician before the result of the estimation was known. The traditional view regarding the value of AcPase determinations in following the progress of the disease, succinctly summarized by Woodard (1959) , has also been thrown in doubt (Schwartz, Greenberg, and Bodansky, 1963; Prout and Brewer, 1967) . It has, moreover, been shown by Mobley and Frank (1968) that anaplastic tumours neither produce nor secrete AcPase and, even in the presence of bone metastases, are usually associated with normal levels.
The method presented appears to be quite sensitive in detecting lesions before they reach the stage of bone metastases. Against this must be set the higher incidence of elevations among patients with other prostatic abnormalities or even apparently normal prostates, although the influence of prostatic massage is known in some of these cases and suspected in others. It is also very difficult to exclude a small and clinically undetectable lesion in these patients who did not come to operation, except by careful follow up. At the present there is no method of choice for AcPase determination, but the evidence of this report suggests that the method described is worthy of serious consideration by those laboratories starting to develop the test, or unhappy with their current method.
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